An NPR investigation found stalled confirmatory trials and lax enforcement are plaguing the FDA’s accelerated approval of drugs for urgent medical needs.
An NPR investigation found stalled confirmatory trials and lax enforcement are plaguing the FDA’s accelerated approval of drugs for urgent medical needs.